Glow 70mg

• Peptide Information

• Refunds & Returns

Note: Peptides will arrive in a powder form for maximum stability!!!

Dragon Pharma GLOW Peptide – Premium 70 mg Research Blend

Elevate your research with Dragon Pharma GLOW peptide, a powerful synergy of three advanced peptides meticulously formulated for laboratory exploration. Designed for researchers who demand precision and quality, this 70 mg blend combines BPC‑157 (10 mg), TB‑500 (10 mg), and GHK‑Cu (50 mg) — each chosen for its unique role in tissue repair, cellular health, and regenerative pathways.

Why GLOW peptide blend Stands Out:

• Synergistic Research Blend: Each peptide targets a different aspect of cellular repair and regeneration, providing a versatile tool for preclinical studies.

• High-Purity, Lab-Grade Peptides: Lyophilized powder ensures precise dosing and stability for reliable experimental outcomes.

• Comprehensive Tissue Support: Explore mechanisms of angiogenesis, anti-inflammatory signaling, collagen production, and extracellular matrix remodeling.

• Scientifically Backed: Every component of this blend has been studied in preclinical models for its potential to enhance cellular repair and regeneration.

Peptide Breakdown

1. BPC‑157 (10 mg): Vascular Repair & Fibroblast Activation

BPC‑157, a 15-amino-acid peptide derived from a naturally occurring body protection compound, plays a central role in tissue repair. Preclinical studies demonstrate its ability to stimulate fibroblast proliferation and migration, key processes in wound healing. It also promotes angiogenesis — the formation of new blood vessels — which ensures oxygen and nutrient delivery to damaged tissue, accelerating repair and enhancing tissue resilience.

2. TB‑500 (10 mg): Cell Migration & Tissue Remodeling

TB‑500 is a synthetic peptide fragment of Thymosin β4, well-known for its ability to regulate actin, a critical protein in cellular structure and movement. By enhancing cell motility, TB‑500 supports tissue remodeling and structural repair. Preclinical studies show it can reduce fibrosis (scar tissue formation) and improve regenerative outcomes in connective tissues such as tendons, ligaments, and muscle.

3. GHK‑Cu (50 mg): Collagen Production & Extracellular Matrix Support

GHK‑Cu is a copper-binding tripeptide that influences gene expression in ways that support tissue regeneration. It stimulates collagen synthesis, reinforces the extracellular matrix (ECM), and exhibits antioxidant properties. These effects are critical for maintaining tissue integrity, enhancing wound healing, and promoting cellular regeneration in preclinical models.

Synergistic Effect of the GLOW Blend

When combined in the Dragon Pharma GLOW peptide, these three peptides target complementary pathways: BPC‑157 accelerates vascular and connective tissue repair, TB‑500 enhances cellular mobility and structural remodeling, and GHK‑Cu reinforces the extracellular framework while promoting collagen synthesis. Together, they offer a powerful, research-grade tool to explore tissue repair, regenerative biology, and cellular recovery in vitro.

Products Usage: This product is intended solely for use as a research chemical. It is designated strictly for in vitro testing and laboratory experimentation purposes only. All information provided on this website is for educational purposes. Under no circumstances should this product be introduced into the human or animal body, as such actions are strictly prohibited by law. This product must only be handled by licensed and qualified professionals. It is not classified as a drug, food, or cosmetic and must not be misbranded, misused, or mislabeled as such.